Assessment of the potential effect of incremental increases in folic acid intake on neural tube defects in Australia and New Zealand

Australian and New Zealand Journal of Public Health

Volumn 30, Issue 4, 2006, Pages 369-374

  Carol, Bower ^a   de Klerk, Nicholas ^a   Milne, Elizabeth ^a   Hickling, Siobhan ^b   Ambrosini, Gina ^b   Geelhoed, Elizabeth ^b   Flicker, Leon ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ACCURACY; ANENCEPHALUS; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG UTILIZATION; ENCEPHALOCELE; FEMALE; FOOD COMPOSITION; HEALTH PROGRAM; HUMAN; INDIGENOUS PEOPLE; INFANT; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; NEURAL TUBE DEFECT; NEW ZEALAND; OUTCOME ASSESSMENT; PREGNANCY TERMINATION; PREVALENCE; PRIMARY PREVENTION; TREATMENT OUTCOME;

AUSTRALIA; FOLIC ACID; HUMANS; INFANT, NEWBORN; NEURAL TUBE DEFECTS; NEW ZEALAND; RISK ASSESSMENT;

EID: 33748431824     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.2006.tb00851.x     Document Type: Article

References (40)

1. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins to prevent neural tube defects (Cochrane review). In: The Cochrane Database Systematic Reviews, Issue 3, 2001. Oxford: Update Software; 2001.
2. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, et al. Prevention of neural-tube defects with folic acid in China. N Engl J Med. 1999;341:1485-90.
3. Bower C, Stanley FJ. Periconceptional vitamin supplementation and neural tube defects: evidence from a case-control study in Western Australia and a review of recent publications. J Epidemiol Community Health. 1992;46:157-61.
4. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-5.
5. Kirke PN, Daly LE, Elwood JH. A randomised trial of low dose folic acid to prevent neural tube defects. Arch Dis Child. 1992;67:1442-6.
6. Laurence KM, Campbell H. Trial of folate treatment to prevent recurrence of neural tube defect. Br Med J. 1981;282:2131.
7. Mills JL, Rhoads GG, Simpson JL. The absence of a relation between the periconceptional use of vitamins and neural tube defects. N Engl J Med. 1989;321:430-5.
8. Milunsky A, Jick H, Jick SS, Bruell CL. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. J Am Med Assoc. 1989;262:2847-52.
9. Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. J Am Med Assoc. 1988;260:3141-5.
10. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology. 1995;6:219-26.
11. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet. 1980;1:339-40.
12. Vergel RG, Sanchez LR, Heredero BL, Rodriguez PL, Martinez AJ. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn. 1990;10:149-52.
13. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. J Am Med Assoc. 1993;269:1257-61.
14. Bower C, Miller M, Payne J, Serna P, de Klerk N, Stanley FJ. Folate promotion in Western Australia and the prevention of neural tube defects. Aust N Z J Public Health. 2004;28:458-64.
15. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust. 1989;150:613-19.
16. Friel JK, Freckler M, Fraser FC. Nutritional patterns of mothers of children with neural tube defects in Newfoundland. Am J Med Genet. 1995;55:195-9.
17. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med. 1993;86:703-8.
18. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. J Am Med Assoc. 1995;274:1698-702.
19. Moore LL, Bradlee ML, Singer MR, Rothman KJ, Milunsky A. Folate intake and the risk of neural tube defects: an estimation of dose-response. Epidemiology. 2003;14:200-5.
20. Wald N, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet. 2001;358:2069-73.
21. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-7.
22. Wald NJ. Folic acid and the prevention of neural tube defects: maternal nutrition and pregnancy outcome. Ann NY Acad Sci. 1993;678:112-29.
23. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. J Am Med Assoc. 2001;285:2981-6.
24. Abraham B, Webb K. Interim Evaluation of the Voluntary Folate Fortification Policy. Canberra (AUST): Commonwealth Department of Health and Aged Care; 2001.
25. Bower C, Eades S, Payne J, D'Antoine H, Stanley F. Trends in neural tube defects in Western Australia in Indigenous and non-Indigenous populations. Paediatr Perinat Epidemiol. 2004;18:277-80.
26. Borman B, Cryer C. The prevalence of anencephalus and spina bifida in New Zealand. J Paediatr Child Health. 1993;29:282-8.
27. Maats FH, Crowther CA. Patterns of vitamin, mineral and herbal supplement use prior to and during pregnancy. Aust N Z J Obstet Gynaecol. 2002;42: 494-6.
28. Chan A, Haan EA. Universal periconceptional folate supplementation: chasing a dream? Med J Aust. 2000;173:223.
29. Allen T, Thomson WR, Emmerton LM, Poulton R. Nutritional supplement use among 26-year-olds. N Z Med J. 2000;113:274-7.
30. Australian Institute for Health and Welfare. Australia's Babies: Their Health and Wellbeing. Canberra (AUST): AIHW; 2004. Report No.: 21.
31. Bower C, Hobbs M, Carney A, Simpson. Neural tube defects in Western Australia 1966-81 and a review of Australian data 1942-81. J Epidemiol Community Health. 1984;38:208-13.
32. Hertrampf E, Cortes F, Erickson JD, Cayazzo M, Freire W, Bailey LB, et al. Consumption of folic acid-fortified bread improves folate status in women of reproductive age in Chile. J Nutr. 2003;133:3166-9.
33. Castilla EE, Orioli IM, Lopez-Camelo JS, Dutra MD, Nazer-Herrera J. Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in south America. Am J Med Genet. 2003;123 Part A: 123-8.
34. Liu S, West R, Randell E, Longerich L, O'Connor KS, Scott H, et al. A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy Childbirth. 2004;4:20.
35. Bower C, Knowles S, Nicol D. Changes in folate supplementation, and in serum and red cell folate levels in antenatal patients over the course of a health promotion project for the prevention of neural tube defects. Aust N Z J Obstet Gynaecol. 1997;37:267-71.
36. Ferguson EL, Skeaff CM, Bourn DM, Nixon M, Parnell WR. Folate Status of Representative Populations in Dunedin. Issues for Folate Fortification. Dunedin (NZ): Department of Human Nutrition and Department of Food Science; University of Otago; 1999.
37. Norsworthy B, Skeaff CM, Adank C, Green TJ. Effects of once-a-week or daily folic acid supplementation on red blood cell folate concentrations in women. Eur J Clin Nutr. 2004;58:548-54.
38. Venn BJ, Mann JI, Williams SM, Riddell LJ, Chisholm A, Harper MJ, et al. Dietary counseling to increase natural folate intake: a randomized, placebo-controlled trial in free-living subjects to assess effects on serum folate and plasma total homocysteine. Am J Clin Nutr. 2002;76:758-65.
39. Venn BJ, Mann JI, Williams SM, Riddell LJ, Chisholm A, Harper MJ, et al. Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial. Eur J Clin Nutr. 2002;56:748-54.
40. Lawrence M. Assessing the case for mandatory folate fortification: policy-making in the face of scientific uncertainties. Aust N Z J Public Health. 2005;29:328-30.